SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-009769
Filing Date
2018-05-14
Accepted
2018-05-14 16:11:22
Documents
55
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sphs20180331_10q.htm 10-Q 993037
2 EXHIBIT 31.1 ex_113009.htm EX-31.1 11238
3 EXHIBIT 31.2 ex_113010.htm EX-31.2 12401
4 EXHIBIT 32.1 ex_113011.htm EX-32.1 6769
5 EXHIBIT 32.2 ex_113012.htm EX-32.2 6739
  Complete submission text file 0001437749-18-009769.txt   3773882

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sphs-20180331.xml EX-101.INS 719616
7 XBRL TAXONOMY EXTENSION SCHEMA sphs-20180331.xsd EX-101.SCH 41866
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sphs-20180331_cal.xml EX-101.CAL 28469
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sphs-20180331_def.xml EX-101.DEF 250035
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sphs-20180331_lab.xml EX-101.LAB 211291
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sphs-20180331_pre.xml EX-101.PRE 266788
Mailing Address 1258 PROSPECT STREET LA JOLLA CA 92037
Business Address 1258 PROSPECT STREET LA JOLLA CA 92037 858-777-1760
SOPHIRIS BIO INC. (Filer) CIK: 0001563855 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36054 | Film No.: 18830698
SIC: 2834 Pharmaceutical Preparations